Pascal Vranckx
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 84
- Acute Myocardial Infarction Research 46
- Atrial Fibrillation Management and Outcomes 45
- Cardiac Valve Diseases and Treatments 20
- Surgery 89
- Coronary Interventions and Diagnostics 65
- Co-authors
- Roxana Mehran (23 shared papers)Donald E. Cutlip (18 shared papers)Patrick W. Serruys (48 shared papers)Stephan Windecker (45 shared papers)Mitchell W. Krucoff (7 shared papers)Philippe Gabríel Steg (17 shared papers)Marco Valgimigli (73 shared papers)Marie‐Angèle Morel (6 shared papers)
- Journals
- Journal of the American College of Cardiology (34 papers)European Heart Journal (33 papers)EuroIntervention (30 papers)European Heart Journal Acute Cardiovascular Care (25 papers)JACC: Cardiovascular Interventions (22 papers)
- Partner nations
- BelgiumSwitzerlandNetherlands
In The Last Decade
Pascal Vranckx
281 papers receiving 57.5k citations
Pascal Vranckx's Hit Papers
Peers
Comparison fields: 5 of 173
- Cardiology and Cardiovascular Medicine 35.9k
- Internal Medicine 3.3k
- Surgery 19.0k
- Radiology, Nuclear Medicine and Imaging 7.0k
- Emergency Medicine 1.5k
Countries citing papers authored by Pascal Vranckx
This map shows the geographic impact of Pascal Vranckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Vranckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Vranckx more than expected).
Fields of papers citing papers by Pascal Vranckx
This network shows the impact of papers produced by Pascal Vranckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Vranckx. The network helps show where Pascal Vranckx may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Vranckx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 302 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Hit paper breakdown → | 2017 | 7355 |
| 2 | 2018 ESC/EACTS Guidelines on myocardial revascularization Hit paper breakdown → | 2018 | 5221 |
| 3 | Clinical End Points in Coronary Stent Trials Hit paper breakdown → | 2007 | 4870 |
| 4 | Standardized Bleeding Definitions for Cardiovascular Clinical Trials Hit paper breakdown → | 2011 | 3703 |
| 5 | 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Hit paper breakdown → | 2020 | 3683 |
| 6 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2) Hit paper breakdown → | 2012 | 3105 |
| 7 | 2023 ESC Guidelines for the management of acute coronary syndromes Hit paper breakdown → | 2023 | 2679 |
| 8 | Third universal definition of myocardial infarction Hit paper breakdown → | 2012 | 2464 |
| 9 | 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS Hit paper breakdown → | 2017 | 2277 |
| 10 | Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Hit paper breakdown → | 2012 | 1514 |
| 11 | Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium Hit paper breakdown → | 2011 | 1071 |
| 12 | Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial Hit paper breakdown → | 2015 | 966 |
| 13 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document† Hit paper breakdown → | 2012 | 902 |
| 14 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document Hit paper breakdown → | 2012 | 787 |
| 15 | Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document Hit paper breakdown → | 2018 | 783 |
| 16 | Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 671 |
| 17 | Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials Hit paper breakdown → | 2011 | 661 |
| 18 | 2018 ESC/EACTS Guidelines on myocardial revascularization Hit paper breakdown → | 2018 | 636 |
| 19 | Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 607 |
| 20 | Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Hit paper breakdown → | 2018 | 600 |
About Pascal Vranckx
Pascal Vranckx is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Radiology, Nuclear Medicine and Imaging and Emergency Medicine, having authored 302 papers that have together received 59.2k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (84 papers), Coronary Interventions and Diagnostics (65 papers), Acute Myocardial Infarction Research (46 papers), Atrial Fibrillation Management and Outcomes (45 papers), Cardiac Imaging and Diagnostics (22 papers), Mechanical Circulatory Support Devices (20 papers), Cardiac Valve Diseases and Treatments (20 papers) and Venous Thromboembolism Diagnosis and Management (14 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (35.9k citations), Internal Medicine (3.3k citations), Surgery (19.0k citations), Radiology, Nuclear Medicine and Imaging (7.0k citations) and Emergency Medicine (1.5k citations). Pascal Vranckx has collaborated with scholars based in Belgium, Switzerland and Netherlands. Frequent co-authors include Roxana Mehran, Donald E. Cutlip, Patrick W. Serruys, Stephan Windecker, Mitchell W. Krucoff, Philippe Gabríel Steg, Marco Valgimigli, Marie‐Angèle Morel, Gerrit‐Anne van Es and Eugene Patrick McFadden. Their work appears in journals such as Journal of the American College of Cardiology, European Heart Journal, EuroIntervention, European Heart Journal Acute Cardiovascular Care and JACC: Cardiovascular Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.